Differences and Clinical Significance of Serum 25-Hydroxyvitamin D3 and Vasohibin-1 (VASH-1) Levels in Patients with Diabetic Nephropathy and Different Renal Injuries

References

• Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):117–124. doi:10.2174/1570161117666190502103733
   PubMed Web of Science ®Google Scholar
• Ye YW, Yan ZY, He LP, Li CP. More studies are necessary to establish the effectiveness of Jinhuang powder in the treatment of diabetic foot. World J Diabetes. 2022;13(7):581–583. doi:10.4239/wjd.v13.i7.581
   PubMed Web of Science ®Google Scholar
• He LP, Song YX, Zhu T, Gu W, Liu CW. Progress in the Relationship between Vitamin D Deficiency and the Incidence of Type 1 Diabetes Mellitus in Children. J Diabetes Res. 2022;2022:5953562. doi:10.1155/2022/5953562
   PubMed Web of Science ®Google Scholar
• Shen W, He LP, Zhou LL. Obesity is associated with colitis in women but not necessarily causal relationship. World J Clin Cases. 2022;10(26):9542–9544. doi:10.12998/wjcc.v10.i26.9542
   PubMed Web of Science ®Google Scholar
• Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic Kidney Disease. Prim Care. 2020;47(4):645–659. doi:10.1016/j.pop.2020.08.004
   PubMed Web of Science ®Google Scholar
• Yamanouchi M, Furuichi K, Hoshino J, Ubara Y, Wada T. Nonproteinuric diabetic kidney disease. Clin Exp Nephrol. 2020;24(7):573–581. doi:10.1007/s10157-020-01881-0
   PubMed Web of Science ®Google Scholar
• Zhou B, Jin YQ, He LP. Loss of skeletal muscle mass is not specific to type 2 diabetes. World J Diabetes. 2022;13(8):665–667. doi:10.4239/wjd.v13.i8.665
   PubMed Web of Science ®Google Scholar
• Koch EAT, Nakhoul R, Nakhoul F, Nakhoul N. Autophagy in diabetic nephropathy: a review. Int Urol Nephrol. 2020;52(9):1705–1712. doi:10.1007/s11255-020-02545-4
   PubMed Web of Science ®Google Scholar
• Ren XH, Ye YW, He LP. Baseline differences may impact on relationship between dietary tryptophan and risk of obesity and type 2 diabetes. World J Clin Cases. 2022;10(21):7617–7619. doi:10.12998/wjcc.v10.i21.7617
   PubMed Web of Science ®Google Scholar
• Perez-Lopez L, Boronat M, Melian C, Brito-Casillas Y, Wagner AM. Animal Models and Renal Biomarkers of Diabetic Nephropathy. Adv Exp Med Biol. 2021;1307:521–551. doi:10.1007/5584_2020_527
   PubMed Web of Science ®Google Scholar
• Yasuda I, Hasegawa K, Sakamaki Y, et al. Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy. J Am Soc Nephrol. 2021;32(6):1355–1370. doi:10.1681/ASN.2020081188
   PubMed Web of Science ®Google Scholar
• Saini DC, Kochar A, Poonia R. Clinical correlation of diabetic retinopathy with nephropathy and neuropathy. Indian J Ophthalmol. 2021;69(11):3364–3368. doi:10.4103/ijo.IJO_1237_21
   PubMed Web of Science ®Google Scholar
• Farber E, Hanut A, Tadmor H, Ruth A, Nakhoul F, Nakhoul N. Autophagy and Diabetic Nephropathy. Harefuah. 2021;160(11):740–745.
   PubMedGoogle Scholar
• Russo G, Piscitelli P, Giandalia A, et al. Atherogenic dyslipidemia and diabetic nephropathy. J Nephrol. 2020;33(5):1001–1008. doi:10.1007/s40620-020-00739-8
   PubMed Web of Science ®Google Scholar
• Ji J, Tao P, Wang Q, Li L, Xu Y. SIRT1: mechanism and Protective Effect in Diabetic Nephropathy. Endocr Metab Immune Disord Drug Targets. 2021;21(5):835–842. doi:10.2174/1871530320666201029143606
   PubMed Web of Science ®Google Scholar
• Tsai IT, Wu CC, Hung WC, et al. FABP1 and FABP2 as markers of diabetic nephropathy. Int J Med Sci. 2020;17(15):2338–2345. doi:10.7150/ijms.49078
   PubMed Web of Science ®Google Scholar
• Lin ZJ, Zhang QW, Yu XL, Zhou B, Liu CW, He LP. Different nutrient compositions in diet and taking hypoglycemic drugs can modulate gut microbial flora. World J Diabetes. 2022;13(9):799–801. doi:10.4239/wjd.v13.i9.799
   PubMed Web of Science ®Google Scholar
• Popykhova EB, Ivanov AN, Stepanova TV, Lagutina DD, Savkina AA. Diabetic Nephropathy. - possibilities of early laboratory diagnostics and course prediction (review of literature). Klin Lab Diagn. 2021;66(10):593–602. doi:10.51620/0869-2084-2021-66-10-593-602
   PubMedGoogle Scholar
• Salem M, Sallam AM, Abdel-Aleem E, El-Mesallamy HO. Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: a Randomized Trial. Horm Metab Res. 2021;53(7):470–477. doi:10.1055/a-1517-6643
   PubMedGoogle Scholar
• Jing Z, Hu L, Su Y, Ying G, Ma C, Wei J. Potential signaling pathway through which Notch regulates oxidative damage and apoptosis in renal tubular epithelial cells induced by high glucose. J Recept Signal Transduct Res. 2021;41(4):357–362. doi:10.1080/10799893.2020.1810706
   PubMed Web of Science ®Google Scholar
• Lee YH, Kim KP, Park SH, et al. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease. Nephrol Dial Transplant. 2021;36(2):295–305. doi:10.1093/ndt/gfz168
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Looker HC, Satake E, et al. Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes. Kidney Int. 2022;102(2):370–381. doi:10.1016/j.kint.2022.04.022
   PubMed Web of Science ®Google Scholar
• Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–390. doi:10.1038/s41581-020-0278-5
   PubMed Web of Science ®Google Scholar
• Chertow GM, Vart P, Jongs N, et al. Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease. J Am Soc Nephrol. 2021;32(9):2352–2361. doi:10.1681/ASN.2021020167
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Mimura I, Tanaka T, Nangaku M. Treatment of Diabetic Kidney Disease: current and Future. Diabetes Metab J. 2021;45(1):11–26. doi:10.4093/dmj.2020.0217
   PubMed Web of Science ®Google Scholar
• Frampton JE. Finerenone: first Approval. Drugs. 2021;81(15):1787–1794. doi:10.1007/s40265-021-01599-7
   PubMed Web of Science ®Google Scholar
• Piperidou A, Loutradis C, Sarafidis P. SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives. J Hum Hypertens. 2021;35(1):12–25. doi:10.1038/s41371-020-00393-4
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, Lima-Posada I, Bakris GL, Jaisser F. Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects. Nat Rev Nephrol. 2022;18(1):56–70. doi:10.1038/s41581-021-00490-8
   PubMed Web of Science ®Google Scholar
• Barutta F, Bellini S, Canepa S, Durazzo M, Gruden G. Novel biomarkers of diabetic kidney disease: current status and potential clinical application. Acta Diabetol. 2021;58(7):819–830. doi:10.1007/s00592-020-01656-9
   PubMed Web of Science ®Google Scholar
• Ueki K, Sasako T, Okazaki Y, et al. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2021;99(1):256–266. doi:10.1016/j.kint.2020.08.012
   PubMed Web of Science ®Google Scholar
• Cao Z, Huang D, Tang C, et al. Pyroptosis in diabetes and diabetic nephropathy. Clin Chim Acta. 2022;531:188–196. doi:10.1016/j.cca.2022.04.011
   PubMed Web of Science ®Google Scholar
• Wu L, Liu C, Chang DY, et al. Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney Int. 2021;100(1):107–121. doi:10.1016/j.kint.2021.02.025
   PubMed Web of Science ®Google Scholar
• Packer M. Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors. J Am Soc Nephrol. 2020;31(5):907–919. doi:10.1681/ASN.2020010010
   PubMed Web of Science ®Google Scholar
• Yuan Y, Yuan L, Li L, et al. Mitochondrial transfer from mesenchymal stem cells to macrophages restricts inflammation and alleviates kidney injury in diabetic nephropathy mice via PGC-1alpha activation. Stem Cells. 2021;39(7):913–928. doi:10.1002/stem.3375
   PubMed Web of Science ®Google Scholar
• Jung SW, Moon JY. The role of inflammation in diabetic kidney disease. Korean J Intern Med. 2021;36(4):753–766. doi:10.3904/kjim.2021.174
   PubMed Web of Science ®Google Scholar
• Jiang WJ, Xu CT, Du CL, et al. Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy. Theranostics. 2022;12(1):324–339. doi:10.7150/thno.63735
   PubMed Web of Science ®Google Scholar
• Pan C, He L. Blood Lipids Are Not Specific for Stroke Risk. Biol Trace Elem Res. 2023;201(2):527–528. doi:10.1007/s12011-022-03184-9
   PubMed Web of Science ®Google Scholar
• Ren XH, Pan RJ, Li ZP, He LP. The Difference in Body Type May Modify the Relationship Between Dietary Mineral Intake and Hypertension Among Korean Adults. Biol Trace Elem Res. 2023;201(4):1670–1671. doi:10.1007/s12011-022-03310-7
   PubMed Web of Science ®Google Scholar
• Shi J, He L. Long-Term Use of Anti-Coronary Heart Disease Medications May Impact the Serum Zinc Concentration. Biol Trace Elem Res. 2023;201(1):1. doi:10.1007/s12011-022-03115-8
   PubMed Web of Science ®Google Scholar
• Song YX, He LP, Li CP. The Relationship between Serum Calcium Level and Risk Factor of Pregnancy-Induced Hypertension: a Meta-Analysis. Clin Exp Obstet Gyn. 2023;50(3):66.
   Web of Science ®Google Scholar
• Wang Y, Pan R, He L. Taking Medication for Diabetes May Modify the Link Between Serum Zinc Concentrations and Prediabetes and Diabetes in the General Population. Biol Trace Elem Res. 2023;201:1118–1119. doi:10.1007/s12011-022-03251-1
   PubMed Web of Science ®Google Scholar
• Guo X, Wu Y, Zhang C, Wu L, Qin L, Liu T. Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism. Drug Des Devel Ther. 2021;15:1577–1594. doi:10.2147/DDDT.S297683
   PubMed Web of Science ®Google Scholar
• Ma L, Wu F, Shao Q, Chen G, Xu L, Lu F. Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway. Drug Des Devel Ther. 2021;15:3207–3221. doi:10.2147/DDDT.S319260
   PubMed Web of Science ®Google Scholar
• He LP, Zhou ZX, Li CP. Narrative review of ferroptosis in obesity. J Cell Mol Med. 2023;27(7):920–926. doi:10.1111/jcmm.17701
   PubMed Web of Science ®Google Scholar
• Su WY, Li Y, Chen X, et al. Ginsenoside Rh1 Improves Type 2 Diabetic Nephropathy through AMPK/PI3K/Akt-Mediated Inflammation and Apoptosis Signaling Pathway. Am J Chin Med. 2021;49(5):1215–1233. doi:10.1142/S0192415X21500580
   PubMedGoogle Scholar
• Satari M, Bahmani F, Reiner Z, et al. Metabolic and Anti-inflammatory Response to Melatonin Administration in Patients with Diabetic Nephropathy. Iran J Kidney Dis. 2021;1(1):22–30.
   PubMedGoogle Scholar